703-1299

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
703 (USA) · Dr. Okafor
consented 2012-09-12

AEs

Serious

Dropout signal

–

Adverse events

moderate assessed

Moderate GLAUCOMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 1992; relationship: NONE

mild assessed

Mild HYPOTENSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-01 (study day 171.0); relationship: REMOTE

moderate assessed

Moderate HYPOTENSION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-01 (study day 171.0); relationship: REMOTE

moderate assessed

Moderate MYOCARDIAL INFARCTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-13 (study day 183.0); relationship: REMOTE

mild assessed

Mild TACHYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-01 (study day 171.0); relationship: REMOTE

moderate assessed

Moderate TACHYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-01 (study day 171.0); relationship: REMOTE

mild assessed

Mild UPPER RESPIRATORY TRACT INFECTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-27 (study day 16.0); relationship: NONE

mild assessed

Mild UPPER RESPIRATORY TRACT INFECTION — outcome: RECOVERED/RESOLVED; onset 2012-09-27 (study day 16.0); relationship: NONE

Data queries

No data queries.